Want to join the conversation?
$CAH 4Q15 Call: We closed the acquisition of Harvard Drug in early July and this will further fuel our growth in generics. Specialty business continues its strong growth and we expect specialty business have made some important moves in the last 18-24 months.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?